- Total revenue increased year-over-year with Greenbrook integration driving clinic growth.
- Net loss improved to approx. $(1.7)M or $(0.02) per share compared to $(9.0)M or $(0.13) in Q3 2025.
- Cash and cash equivalents stood at $22.1M as of September 30, 2026.
Signal #129352 · SEC 8-K
$STIM SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $STIM filing catalyst
Why did $STIM trigger an AI stock catalyst alert?
$STIM triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +3.0/10). Headline: Neuronetics Reports Q3 2026: Revenue Up, Net Loss Shrinks to $0.02 Per Share. Key points: - Total revenue increased year-over-year with Greenbrook integration driving clinic growth. - Net loss improved to approx. $(1.7)M or $(0.02) per share compared to $(9.0)M or $(0.13) in Q3 2025. - Cash and cash equivalents stood at $22.1M as of September 30, 2026.
How did $STIM stock react after the SEC filing?
After the SEC 8-K for $STIM, observed market reaction: T0 price $2.26. Past moves do not guarantee future results.
Where can I get real-time $STIM SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $STIM via Telegram and the VIP Web Terminal from €10/month.